BDNF- and VEGF-Responsive Stimulus to an NGF Mimic Cyclic Peptide with Copper Ionophore Capability and Ctr1/CCS-Driven Signaling.
暂无分享,去创建一个
I. Naletova | G. Arena | D. La Mendola | A. Pietropaolo | F. Bellia | S. Sciuto | M. Tomasello | F. Attanasio | G. Tabbì | Mariagrazia Fortino | Barbara Tomasello | A. Magrì | Warren R L Cairns | Valentina Greco | Enrico Rizzarelli
[1] L. Rossi,et al. Copper-Dependent Kinases and Their Role in Cancer Inception, Progression and Metastasis , 2022, Biomolecules.
[2] G. Vistoli,et al. Computational Insights into the Sequence-Activity Relationships of the NGF(1–14) Peptide by Molecular Dynamics Simulations , 2022, Cells.
[3] M. Soligo,et al. Intranasal Delivery of Nerve Growth Factor in Neurodegenerative Diseases and Neurotrauma , 2021, Frontiers in Pharmacology.
[4] R. Marmorstein,et al. The copper chaperone CCS facilitates copper binding to MEK1/2 to promote kinase activation. , 2021, The Journal of biological chemistry.
[5] M. Varano,et al. Nerve Growth Factor-Based Therapy in Alzheimer’s Disease and Age-Related Macular Degeneration , 2021, Frontiers in Neuroscience.
[6] A. Magrì,et al. Peptides Derived from Angiogenin Regulate Cellular Copper Uptake , 2021, International journal of molecular sciences.
[7] Suzanne Gascon,et al. Peptides Derived from Growth Factors to Treat Alzheimer’s Disease , 2021, International journal of molecular sciences.
[8] C. Satriano,et al. Metal ion coordination in peptide fragments of neurotrophins: A crucial step for understanding the role and signaling of these proteins in the brain , 2021 .
[9] He Huang,et al. Elucidating Solution Structures of Cyclic Peptides Using Molecular Dynamics Simulations. , 2021, Chemical reviews.
[10] T. Gudasheva,et al. Low‐molecular mimetics of nerve growth factor and brain‐derived neurotrophic factor: Design and pharmacological properties , 2020, Medicinal research reviews.
[11] Chen Zhao,et al. Exploring the Extended Biological Functions of the Human Copper Chaperone of Superoxide Dismutase 1 , 2019, The Protein Journal.
[12] C. Chang,et al. Copper (II) Ions Activate Ligand-Independent Receptor Tyrosine Kinase (RTK) Signaling Pathway , 2019, BioMed research international.
[13] I. Naletova,et al. The Copper(II)-Assisted Connection between NGF and BDNF by Means of Nerve Growth Factor-Mimicking Short Peptides , 2019, Cells.
[14] A. Cuello,et al. The Brain NGF Metabolic Pathway in Health and in Alzheimer’s Pathology , 2019, Front. Neurosci..
[15] M. Eriksdotter,et al. Innovative Therapy for Alzheimer’s Disease-With Focus on Biodelivery of NGF , 2019, Front. Neurosci..
[16] L. F. Aguilar,et al. Differential deregulation of NGF and BDNF neurotrophins in a transgenic rat model of Alzheimer's disease , 2017, Neurobiology of Disease.
[17] C. Satriano,et al. The Inorganic Side of NGF: Copper(II) and Zinc(II) Affect the NGF Mimicking Signaling of the N-Terminus Peptides Encompassing the Recognition Domain of TrkA Receptor , 2016, Front. Neurosci..
[18] M. Lascombe,et al. Biophysical Studies of the Induced Dimerization of Human VEGF Receptor 1 Binding Domain by Divalent Metals Competing with VEGF-A , 2016, PloS one.
[19] E. Rizzarelli,et al. Intracellular Bioinorganic Chemistry and Cross Talk Among Different -Omics. , 2016, Current Topics in Medicinal Chemistry.
[20] Y. J. Kang,et al. Featured Article: Effect of copper on nuclear translocation of copper chaperone for superoxide dismutase-1 , 2016, Experimental biology and medicine.
[21] P. Povarnina,et al. Dimeric dipeptide mimetics of the nerve growth factor Loop 4 and Loop 1 activate TRKA with different patterns of intracellular signal transduction , 2015, Journal of Biomedical Science.
[22] Adriana Pietropaolo,et al. A small linear peptide encompassing the NGF N-terminus partly mimics the biological activities of the entire neurotrophin in PC12 cells. , 2015, ACS chemical neuroscience.
[23] P. Alifano,et al. The Role of Rab Proteins in Neuronal Cells and in the Trafficking of Neurotrophin Receptors , 2014, Membranes.
[24] Michelle L. Turski,et al. Copper is required for oncogenic BRAF signaling and tumorigenesis , 2014, Nature.
[25] K. Sawamoto,et al. Vascular regulation of adult neurogenesis under physiological and pathological conditions , 2014, Front. Neurosci..
[26] F. Longo,et al. Small-molecule modulation of neurotrophin receptors: a strategy for the treatment of neurological disease , 2013, Nature Reviews Drug Discovery.
[27] C. Ibáñez,et al. Genetic dissection of neurotrophin signaling through the p75 neurotrophin receptor. , 2012, Cell reports.
[28] L. Manni,et al. Nerve growth factor: from the early discoveries to the potential clinical use , 2012, Journal of Translational Medicine.
[29] S. Howell,et al. Copper influx transporter 1 is required for FGF, PDGF and EGF-induced MAPK signaling. , 2012, Biochemical pharmacology.
[30] Zhen Zhang,et al. Copper Is Required for Cobalt-Induced Transcriptional Activity of Hypoxia-Inducible Factor-1 , 2012, Journal of Pharmacology and Experimental Therapeutics.
[31] A. Magrì,et al. Probing the copper(II) binding features of angiogenin. Similarities and differences between a N-terminus peptide fragment and the recombinant human protein. , 2012, Inorganic chemistry.
[32] G. Arena,et al. The inorganic perspective of nerve growth factor: interactions of Cu2+ and Zn2+ with the N-terminus fragment of nerve growth factor encompassing the recognition domain of the TrkA receptor. , 2011, Chemistry.
[33] A. Magrì,et al. Copper(II) complex formation with a linear peptide encompassing the putative cell binding site of angiogenin. , 2010, Dalton transactions.
[34] Benjamin M. Bulheller,et al. Ultraviolet spectroscopy of protein backbone transitions in aqueous solution: combined QM and MM simulations. , 2010, The journal of physical chemistry. B.
[35] A. Rosenzweig,et al. Structural biology of copper trafficking. , 2009, Chemical reviews.
[36] Fei Ye,et al. Copper Regulation of Hypoxia-Inducible Factor-1 Activity , 2009, Molecular Pharmacology.
[37] M. Yaar,et al. A cyclic peptide that binds p75NTR protects neurones from beta amyloid (1–40)‐induced cell death , 2007, Neuropathology and applied neurobiology.
[38] G. Perini,et al. Functional cooperation between TrkA and p75(NTR) accelerates neuronal differentiation by increased transcription of GAP-43 and p21(CIP/WAF) genes via ERK1/2 and AP-1 activities. , 2007, Experimental cell research.
[39] M. Baron,et al. Vertebrate Ctr1 coordinates morphogenesis and progenitor cell fate and regulates embryonic stem cell differentiation , 2007, Proceedings of the National Academy of Sciences.
[40] L. Reichardt,et al. Neurotrophin-regulated signalling pathways , 2006, Philosophical Transactions of the Royal Society B: Biological Sciences.
[41] P. Carloni,et al. Molecular simulation of the binding of nerve growth factor peptide mimics to the receptor tyrosine kinase A. , 2006, Biophysical journal.
[42] U. Felbor,et al. VEGF receptors on PC12 cells mediate transient activation of ERK1/2 and Akt: comparison of nerve growth factor and vascular endothelial growth factor , 2006, Journal of Negative Results in Biomedicine.
[43] A. Cuello,et al. Activity-dependent release of precursor nerve growth factor, conversion to mature nerve growth factor, and its degradation by a protease cascade. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[44] Steven G Potkin,et al. A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease , 2005, Nature Medicine.
[45] U. Moens,et al. What turns CREB on? , 2004, Cellular signalling.
[46] M. Chao,et al. Neurotrophins and their receptors: A convergence point for many signalling pathways , 2003, Nature Reviews Neuroscience.
[47] Christian Wiesmann,et al. Crystal structure of nerve growth factor in complex with the ligand-binding domain of the TrkA receptor , 1999, Nature.
[48] R. Casareno,et al. The Copper Chaperone CCS Directly Interacts with Copper/Zinc Superoxide Dismutase* , 1998, The Journal of Biological Chemistry.
[49] K. Neet,et al. Characterization of Histidine Residues Essential for Receptor Binding and Activity of Nerve Growth Factor* , 1996, The Journal of Biological Chemistry.
[50] M. Greenberg,et al. Nerve growth factor activates a Ras-dependent protein kinase that stimulates c-fos transcription via phosphorylation of CREB , 1994, Cell.
[51] Tom L. Blundell,et al. New protein fold revealed by a 2.3-Å resolution crystal structure of nerve growth factor , 1991, Nature.
[52] K. Steimer,et al. Cu,Zn superoxide dismutase is a peroxisomal enzyme in human fibroblasts and hepatoma cells. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[53] V. Hamburger,et al. A NERVE GROWTH-STIMULATING FACTOR ISOLATED FROM SARCOM AS 37 AND 180. , 1954, Proceedings of the National Academy of Sciences of the United States of America.
[54] E. Rizzarelli,et al. Neurodegeneration: Metallostasis and Proteostasis , 2011 .
[55] C. Alberini,et al. Transcription factors in long-term memory and synaptic plasticity. , 2009, Physiological reviews.
[56] M. Sofroniew,et al. Nerve growth factor signaling, neuroprotection, and neural repair. , 2001, Annual review of neuroscience.
[57] E. Huang,et al. Neurotrophins: roles in neuronal development and function. , 2001, Annual review of neuroscience.